Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:2010:625105.
doi: 10.1155/2010/625105. Epub 2010 Jun 30.

Nonclassic congenital adrenal hyperplasia

Affiliations

Nonclassic congenital adrenal hyperplasia

Selma Feldman Witchel et al. Int J Pediatr Endocrinol. 2010.

Abstract

Nonclassic congenital adrenal hyperplasia (NCAH) due to P450c21 (21-hydroxylase deficiency) is a common autosomal recessive disorder. This disorder is due to mutations in the CYP21A2 gene which is located at chromosome 6p21. The clinical features predominantly reflect androgen excess rather than adrenal insufficiency leading to an ascertainment bias favoring diagnosis in females. Treatment goals include normal linear growth velocity and "on-time" puberty in affected children. For adolescent and adult women, treatment goals include regularization of menses, prevention of progression of hirsutism, and fertility. This paper will review key aspects regarding pathophysiology, diagnosis, and treatment of NCAH.

PubMed Disclaimer

References

    1. Decourt J, Jayle MF, Baulieu E. Virilisme cliniquement tardif avec excrétion de prégnanetriol et insuffisance de la production du cortisol. Annales d’Endocrinologie. 1957;18(3):416–422. - PubMed
    1. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A. High frequency of nonclassical steroid 21-hydroxylase deficiency. American Journal of Human Genetics. 1985;37(4):650–667. - PMC - PubMed
    1. Wilson RC, Nimkarn S, Dumic M, et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Molecular Genetics and Metabolism. 2007;90(4):414–421. - PMC - PubMed
    1. Lutfallah C, Wang W, Mason JI, et al. Newly proposed hormonal criteria via genotypic proof for type II 3β-hydroxysteroid dehydrogenase deficiency. Journal of Clinical Endocrinology and Metabolism. 2002;87(6):2611–2622. - PubMed
    1. Joehrer K, Geley S, Strasser-Wozak EMC, et al. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11β- hydroxylase deficiency. Human Molecular Genetics. 1997;6(11):1829–1834. - PubMed

LinkOut - more resources